Amlodipine Tablets 5mg (Amlodipine “VTRS”® / アムロジピン錠5mg「VTRS」)

JPY ¥1,900

Japanese Long-acting Calcium Channel Blocker (Amlodipine Besilate 5mg). Oral tablet for hypertension and angina pectoris. 100 tablets [10 tablets (PTP) x 10]. Mfd. by Viatris Healthcare LLC, Japan.

Bulk deal
Quantity Discount Discounted price
5 - 9 8% JPY ¥1,748
10 - 19 12% JPY ¥1,672
20 + 18% JPY ¥1,558
SKU: AML-5-TAB Category:

Description

Product Overview / 商品概要

Amlodipine Tablets 5mg “VTRS” (アムロジピン錠5mg「VTRS」)
Generic: Amlodipine Besilate / アムロジピンベシル酸塩
Therapeutic Category: Antihypertensive and Antianginal Agent; Long-acting Calcium Channel Blocker / 高血圧症・狭心症治療薬 持続性Ca拮抗薬
Manufactured by: Viatris Healthcare LLC / ヴィアトリス・ヘルスケア合同会社

Composition & Specification / 組成・規格

Active Ingredient: Amlodipine Besilate (JP) 6.93mg (equivalent to Amlodipine 5mg) per tablet / 1錠中 日局 アムロジピンベシル酸塩6.93mg(アムロジピンとして5mg)
Additives: Microcrystalline cellulose, Anhydrous calcium hydrogen phosphate, Sodium starch glycolate, Magnesium stearate, Hypromellose, Titanium dioxide, Talc, Carnauba wax / 結晶セルロース、無水リン酸水素カルシウム、デンプングリコール酸ナトリウム、ステアリン酸マグネシウム、ヒプロメロース、酸化チタン、タルク、カルナウバロウ
Appearance: White film-coated tablet; identification code: Amlodipine VT 5; weight: 207mg
外観: 白色フィルムコーティング錠、識別コード: アムロジピン VT 5

Indications / 効能効果

EN: Hypertension; Angina pectoris
JA: ○高血圧症 ○狭心症

Dosage and Administration / 用法用量

EN: Hypertension: The usual adult dose is 2.5 to 5mg of amlodipine once daily orally. The dose may be adjusted according to symptoms; if efficacy is insufficient, the dose may be increased up to 10mg once daily. For pediatric patients aged 6 years and older, the usual dose is 2.5mg of amlodipine once daily orally, with appropriate adjustment based on age, body weight, and symptoms. Angina pectoris: The usual adult dose is 5mg of amlodipine once daily orally, with appropriate adjustment according to symptoms.
JA: 高血圧症: 通常、成人にはアムロジピンとして2.5~5mgを1日1回経口投与する。なお、症状に応じ適宜増減するが、効果不十分な場合には1日1回10mgまで増量することができる。通常、6歳以上の小児には、アムロジピンとして2.5mgを1日1回経口投与する。なお、年齢、体重、症状により適宜増減する。狭心症: 通常、成人にはアムロジピンとして5mgを1日1回経口投与する。なお、症状に応じ適宜増減する。

Contraindications / 禁忌

EN: Patients with a history of hypersensitivity to dihydropyridine compounds
JA: ジヒドロピリジン系化合物に対し過敏症の既往歴のある患者

Regulatory Information / 規制情報

Approval No.: 30200AMX00887
Sales Started: March 2021 / 2021年3月
Classification Code: 872171
Storage: Store at room temperature / 室温保存
Shelf Life: 4 years / 4年

Packaging / 包装

Main Package (for sale): 100 tablets [10 tablets (PTP) x 10] / 100錠[10錠(PTP)×10]
Other Available Packages (by special order): 100 tablets [10 tablets (PTP) x 10], 140 tablets [14 tablets (PTP) x 10], 500 tablets [10 tablets (PTP) x 50], 500 tablets [bottle, bulk]

Full product insert (添付文書) is attached as a downloadable PDF. For detailed precautions, drug interactions, and safety information, please refer to the official package insert.

Additional information

重さ 0.15 kg

Reviews

There are no reviews yet.

Be the first to review “Amlodipine Tablets 5mg (Amlodipine “VTRS”® / アムロジピン錠5mg「VTRS」)”

メールアドレスが公開されることはありません。 ※ が付いている欄は必須項目です

Export from Japan — Amlodipine Tablets 5mg (Amlodipine "VTRS"®

🏭 Supply & Origin

  • Country of Origin: Japan
  • Regulatory Standard: PMDA (Japan) / GMP Compliant
  • Pharmacopoeia: Japanese Pharmacopoeia (JP)
  • Supplier: Mate Co., Ltd. — Licensed Pharmaceutical Wholesaler (License No. B14309, Osaka)
  • Supply Capacity: Full-line sourcing through Japan's regulated distribution channels

🚚 Shipping & Trade Terms

  • Incoterms: FOB Kansai International Airport (KIX)
  • Shipping: Air freight via B/L or AWB
  • Payment: 100% T/T in advance
  • Lead Time: 2-4 weeks after payment confirmation
  • Available Regions: EU, LATAM, APAC, Middle East, Africa

Request a Quotation

For pricing, MOQ, and regulatory documentation, contact our export team:

Email: kurimoto@mate-osaka.co.jp
Tel: +81-72-665-5736

All exports are conducted through proper regulatory procedures including customs clearance, B/L or AWB documentation, and T/T advance payment. We do not engage in hand-carry, cash transactions, or sales to unlicensed parties.